169 related articles for article (PubMed ID: 26180579)
1. Impact of Procyanidins from Different Berries on Caspase 8 Activation in Colon Cancer.
Minker C; Duban L; Karas D; Järvinen P; Lobstein A; Muller CD
Oxid Med Cell Longev; 2015; 2015():154164. PubMed ID: 26180579
[TBL] [Abstract][Full Text] [Related]
2. Silibinin triggers apoptotic signaling pathways and autophagic survival response in human colon adenocarcinoma cells and their derived metastatic cells.
Kauntz H; Bousserouel S; Gossé F; Raul F
Apoptosis; 2011 Oct; 16(10):1042-53. PubMed ID: 21779837
[TBL] [Abstract][Full Text] [Related]
3. Oxaliplatin sensitizes human colon cancer cells to TRAIL through JNK-dependent phosphorylation of Bcl-xL.
El Fajoui Z; Toscano F; Jacquemin G; Abello J; Scoazec JY; Micheau O; Saurin JC
Gastroenterology; 2011 Aug; 141(2):663-73. PubMed ID: 21683075
[TBL] [Abstract][Full Text] [Related]
4. Anticancer agents sensitize tumor cells to tumor necrosis factor-related apoptosis-inducing ligand-mediated caspase-8 activation and apoptosis.
Lacour S; Hammann A; Wotawa A; Corcos L; Solary E; Dimanche-Boitrel MT
Cancer Res; 2001 Feb; 61(4):1645-51. PubMed ID: 11245478
[TBL] [Abstract][Full Text] [Related]
5. Blackberry, black raspberry, blueberry, cranberry, red raspberry, and strawberry extracts inhibit growth and stimulate apoptosis of human cancer cells in vitro.
Seeram NP; Adams LS; Zhang Y; Lee R; Sand D; Scheuller HS; Heber D
J Agric Food Chem; 2006 Dec; 54(25):9329-39. PubMed ID: 17147415
[TBL] [Abstract][Full Text] [Related]
6. Lupulone triggers p38 MAPK-controlled activation of p53 and of the TRAIL receptor apoptotic pathway in human colon cancer-derived metastatic cells.
Lamy V; Bousserouel S; Gossé F; Minker C; Lobstein A; Raul F
Oncol Rep; 2011 Jul; 26(1):109-14. PubMed ID: 21519792
[TBL] [Abstract][Full Text] [Related]
7. [Overcoming acquired resistance to tumor necrosis factor-related apoptosis-inducing ligand by Bcl-XL small interfering RNA in human colon cancer].
Zhu HB; Huang XF; Hu JZ; Zhou W; Chen W; Chen LL; He C
Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):245-9. PubMed ID: 18788624
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor-related apoptosis-inducing ligand retains its apoptosis-inducing capacity on Bcl-2- or Bcl-xL-overexpressing chemotherapy-resistant tumor cells.
Walczak H; Bouchon A; Stahl H; Krammer PH
Cancer Res; 2000 Jun; 60(11):3051-7. PubMed ID: 10850456
[TBL] [Abstract][Full Text] [Related]
9. Lupulone, a hop bitter acid, activates different death pathways involving apoptotic TRAIL-receptors, in human colon tumor cells and in their derived metastatic cells.
Lamy V; Roussi S; Chaabi M; Gossé F; Lobstein A; Raul F
Apoptosis; 2008 Oct; 13(10):1232-42. PubMed ID: 18726190
[TBL] [Abstract][Full Text] [Related]
10. Understanding of tolerance in TRAIL-induced apoptosis and cancelation of its machinery by α-mangostin, a xanthone derivative.
Kumazaki M; Shinohara H; Taniguchi K; Ueda H; Nishi M; Ryo A; Akao Y
Oncotarget; 2015 Sep; 6(28):25828-42. PubMed ID: 26304927
[TBL] [Abstract][Full Text] [Related]
11. MAPK p38 and JNK have opposing activities on TRAIL-induced apoptosis activation in NSCLC H460 cells that involves RIP1 and caspase-8 and is mediated by Mcl-1.
Azijli K; Yuvaraj S; van Roosmalen I; Flach K; Giovannetti E; Peters GJ; de Jong S; Kruyt FA
Apoptosis; 2013 Jul; 18(7):851-60. PubMed ID: 23456625
[TBL] [Abstract][Full Text] [Related]
12. Activation of p38 MAPK by damnacanthal mediates apoptosis in SKHep 1 cells through the DR5/TRAIL and TNFR1/TNF-α and p53 pathways.
Lin FL; Hsu JL; Chou CH; Wu WJ; Chang CI; Liu HJ
Eur J Pharmacol; 2011 Jan; 650(1):120-9. PubMed ID: 20951126
[TBL] [Abstract][Full Text] [Related]
13. TNF-related apoptosis-inducing ligand cooperates with NSAIDs via activated Wnt signalling in (pre)malignant colon cells.
Heijink DM; Jalving M; Oosterhuis D; Sloots IA; Koster R; Hollema H; Kleibeuker JH; Koornstra JJ; de Vries EG; de Jong S
J Pathol; 2011 Feb; 223(3):378-89. PubMed ID: 21171083
[TBL] [Abstract][Full Text] [Related]
14. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.
Ganten TM; Haas TL; Sykora J; Stahl H; Sprick MR; Fas SC; Krueger A; Weigand MA; Grosse-Wilde A; Stremmel W; Krammer PH; Walczak H
Cell Death Differ; 2004 Jul; 11 Suppl 1():S86-96. PubMed ID: 15105837
[TBL] [Abstract][Full Text] [Related]
15. Reactive oxygen species regulate caspase activation in tumor necrosis factor-related apoptosis-inducing ligand-resistant human colon carcinoma cell lines.
Izeradjene K; Douglas L; Tillman DM; Delaney AB; Houghton JA
Cancer Res; 2005 Aug; 65(16):7436-45. PubMed ID: 16103097
[TBL] [Abstract][Full Text] [Related]
16. Osteoblasts display different responsiveness to TRAIL-induced apoptosis during their differentiation process.
Brunetti G; Oranger A; Carbone C; Mori G; Sardone FR; Mori C; Celi M; Faienza MF; Tarantino U; Zallone A; Grano M; Colucci S
Cell Biochem Biophys; 2013; 67(3):1127-36. PubMed ID: 23677859
[TBL] [Abstract][Full Text] [Related]
17. The flavonolignan silibinin potentiates TRAIL-induced apoptosis in human colon adenocarcinoma and in derived TRAIL-resistant metastatic cells.
Kauntz H; Bousserouel S; Gossé F; Raul F
Apoptosis; 2012 Aug; 17(8):797-809. PubMed ID: 22555452
[TBL] [Abstract][Full Text] [Related]
18. A mitochondrial block and expression of XIAP lead to resistance to TRAIL-induced apoptosis during progression to metastasis of a colon carcinoma.
Ndozangue-Touriguine O; Sebbagh M; Mérino D; Micheau O; Bertoglio J; Bréard J
Oncogene; 2008 Oct; 27(46):6012-22. PubMed ID: 18560353
[TBL] [Abstract][Full Text] [Related]
19. Peroxiredoxin I contributes to TRAIL resistance through suppression of redox-sensitive caspase activation in human hepatoma cells.
Song IS; Kim SU; Oh NS; Kim J; Yu DY; Huang SM; Kim JM; Lee DS; Kim NS
Carcinogenesis; 2009 Jul; 30(7):1106-14. PubMed ID: 19406930
[TBL] [Abstract][Full Text] [Related]
20. Berry phenolics selectively inhibit the growth of intestinal pathogens.
Puupponen-Pimiä R; Nohynek L; Hartmann-Schmidlin S; Kähkönen M; Heinonen M; Määttä-Riihinen K; Oksman-Caldentey KM
J Appl Microbiol; 2005; 98(4):991-1000. PubMed ID: 15752346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
